Gilead Sciences, Inc. (GILD)

jimsfordgt40 (< 20) Submitted: 11/16/07 11:33 PM : Start Price: $44.58 GILD Score: 23.13

Sales of Truvada, Viread, Atripla, and Emtriva for the treatment of HIV will continue to grow. GILD trades at a premium to the biotechnology sector based on earnings. But you can't judge biotech or pharma on earnings. It's all about the pipeline and ...

Report this Post Replies: 0 | Reply | Permalink

drstocks1 (44.34) Submitted: 12/31/07 2:15 PM : Start Price: $46.27 GILD Score: 20.80

As a Doc I can onfirm that they are leader in HIV treatment, but more importantly Tenovir an HIV drug will be approved for Hepatiitis B usage. Current data indicate that it will be the most effective anti Hepatitis B drug on the market with no repor...

Report this Post Replies: 0 | Reply | Permalink

louque (85.87) Submitted: 10/08/06 11:38 AM : Start Price: $32.67 GILD Score: 49.05

Gild has new products being approved by the FDA.
This company is progressing and expanding
fairly rapidly.

Report this Post Replies: 0 | Reply | Permalink

badgervance (72.41) Submitted: 10/01/06 4:39 PM : Start Price: $32.49 GILD Score: 49.04

This is my bio-tech pick.

Report this Post Replies: 0 | Reply | Permalink

rodraxx (53.83) Submitted: 9/24/08 12:07 PM : Start Price: $46.34 GILD Score: 12.09

I´ve been buying this stock since 2005 at 23$. Now at this price you have a good chance

Report this Post Replies: 0 | Reply | Permalink

1337n00b (47.49) Submitted: 3/29/08 7:18 PM : Start Price: $50.11 GILD Score: 7.37

We're flying high boys!

Report this Post Replies: 0 | Reply | Permalink

njmiles03 (< 20) Submitted: 12/06/07 9:12 PM : Start Price: $47.45 GILD Score: 20.52

Unfortunately, HIV is not going anywhere for a while; these guys are at the front of the fight.

Report this Post Replies: 0 | Reply | Permalink

unluckyatlove (53.65) Submitted: 11/29/07 2:01 PM : Start Price: $45.50 GILD Score: 22.11

This bio tech company is a leader in this industry with few liabilities. They own Tamaflu for bird flu and have abn outstanding licscensing agreement with Roche. Any big outbreak or scare would give them a big bonus 22% of sales

Report this Post Replies: 1 | Reply | Permalink

JThoben (47.20) Submitted: 4/03/08 8:30 AM : Start Price: $52.15 GILD Score: 6.78

Great biotech company and higher profit margin compared to it's competitor DNA. It pulls in 1.2 billion on income on about 4.5 billion of sales. DNA pulls in about 11 billion on sales and brings in only 2-3 billion.

Report this Post Replies: 0 | Reply | Permalink

doubledown2142 (< 20) Submitted: 6/25/08 3:06 PM : Start Price: $52.86 GILD Score: 6.69

7 straight quarters of beating earnings. Huge margins, huge Returns on Equity, investments, and Assets. The P/E seems high a first glance, but consistency probably backs that up. Large global presence. They seem to be fundamentally sound, with m...

Report this Post Replies: 0 | Reply | Permalink